These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 36114048)

  • 1. Feasibility study of a Response Surveillance Program in locally advanced mid and low rectal cancer to increase organ preservation.
    Boubaddi M; Fleming C; Vendrely V; Frulio N; Salut C; Rullier E; Denost Q
    Eur J Surg Oncol; 2023 Jan; 49(1):237-243. PubMed ID: 36114048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]   [Full Text] [Related]  

  • 3. Watch and Wait for rectal cancer in inflammatory bowel disease.
    Azevedo JGM; Fernandez L; Herrando AI; Santiago I; Pares O; Parvaiz A
    BMJ Case Rep; 2023 Jul; 16(7):. PubMed ID: 37429643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC)? Protocol for the international, multicentre, rolling phase II/III partially randomized patient preference trial evaluating long-course concurrent chemoradiotherapy versus short-course radiotherapy organ preservation approaches.
    Bach SP;
    Colorectal Dis; 2022 May; 24(5):639-651. PubMed ID: 35114057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice Patterns for Organ Preservation in US Patients With Rectal Cancer, 2006-2020.
    Loria A; Tejani MA; Temple LK; Justiniano CF; Melucci AD; Becerra AZ; Monson JRT; Aquina CT; Fleming FJ
    JAMA Oncol; 2024 Jan; 10(1):79-86. PubMed ID: 37943566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimisation of Organ Preservation treatment strategies in patients with rectal cancer with a good clinical response after neoadjuvant (chemo)radiotherapy: Additional contact X-ray brachytherapy versus eXtending the observation period and local excision (OPAXX) - protocol for two multicentre, parallel, single-arm, phase II studies.
    Geubels BM; van Triest B; Peters FP; Maas M; Beets GL; Marijnen CAM; Custers PA; Rutten HJT; Theuws JCM; Verrijssen AE; Cnossen JS; Burger JWA; Grotenhuis BA
    BMJ Open; 2023 Dec; 13(12):e076866. PubMed ID: 38159950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Nonoperative Management of Rectal Cancer Feasible?
    Quezada-Diaz FF; Smith JJ
    Adv Surg; 2023 Sep; 57(1):141-154. PubMed ID: 37536849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ Preservation in Rectal Cancer.
    Yuval JB; Thompson HM; Garcia-Aguilar J
    J Gastrointest Surg; 2020 Aug; 24(8):1880-1888. PubMed ID: 32314234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sense and non-sense of imaging in the era of organ preservation for rectal cancer.
    Ou X; van der Reijd DJ; Lambregts DM; Grotenhuis BA; van Triest B; Beets GL; Beets-Tan RG; Maas M
    Br J Radiol; 2023 Nov; 96(1151):20230318. PubMed ID: 37750870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdisciplinary Spanish consensus on a watch-and-wait approach for rectal cancer.
    Safont MJ; García-Figueiras R; Hernando-Requejo O; Jimenez-Rodriguez R; Lopez-Vicente J; Machado I; Ayuso JR; Bustamante-Balén M; De Torres-Olombrada MV; Domínguez Tristancho JL; Fernández-Aceñero MJ; Suarez J; Vera R
    Clin Transl Oncol; 2024 Apr; 26(4):825-835. PubMed ID: 37787973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.
    Thompson HM; Omer DM; Lin S; Kim JK; Yuval JB; Verheij FS; Qin LX; Gollub MJ; Wu AJ; Lee M; Patil S; Hezel AF; Marcet JE; Cataldo PA; Polite BN; Herzig DO; Liska D; Oommen S; Friel CM; Ternent CA; Coveler AL; Hunt SR; Garcia-Aguilar J;
    JAMA Netw Open; 2024 Jan; 7(1):e2350903. PubMed ID: 38194231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Watch & wait - Post neoadjuvant imaging for rectal cancer.
    El Homsi M; Bercz A; Chahwan S; Fernandes MC; Javed-Tayyab S; Golia Pernicka JS; Nincevic J; Paroder V; Ruby L; Smith JJ; Petkovska I
    Clin Imaging; 2024 Jun; 110():110166. PubMed ID: 38669916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Options for Distal Rectal Cancer in the Era of Organ Preservation.
    Wang C; Liu X; Wang W; Miao Z; Li X; Liu D; Hu K
    Curr Treat Options Oncol; 2024 Apr; 25(4):434-452. PubMed ID: 38517596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case Report of Organ Preservation by Total Neoadjuvant Therapy and Local Excision for Lower Rectal Cancer].
    Imaoka H; Ieki H; Yamashita S; Ichikawa T; Uratani R; Shimura T; Kitajima T; Kawamura M; Yasuda H; Okugawa Y; Morimoto Y; Okita Y; Yoshiyama S; Ohi M; Toiyama Y
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1866-1868. PubMed ID: 38303234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Light and shadow of watch-and-wait strategy in rectal cancer: oncological result, clinical outcomes, and cost-effectiveness analysis.
    Ferri V; Vicente E; Quijano Y; Duran H; Diaz E; Fabra I; Malave L; Ruiz P; Costantini G; Pizzuti G; Cubillo A; Rubio MC; Cañamaque LG; Alfonsel JN; Caruso R
    Int J Colorectal Dis; 2023 Dec; 38(1):277. PubMed ID: 38051359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Crying Need for a Better Response Assessment in Rectal Cancer.
    Amintas S; Giraud N; Fernandez B; Dupin C; Denost Q; Garant A; Frulio N; Smith D; Rullier A; Rullier E; Vuong T; Dabernat S; Vendrely V
    Curr Treat Options Oncol; 2023 Nov; 24(11):1507-1523. PubMed ID: 37702885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which tumour factors preclude organ preservation in patients with rectal cancer?
    Hołdakowska A; Kurkowska K; Pietrzak L; Michalski W; Rutkowski A; Olesiński T; Cencelewicz A; Rydziński M; Socha J; Bujko K
    Radiother Oncol; 2024 Feb; 191():110054. PubMed ID: 38104780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for a national audit of the watch-and-wait approach in patients with rectal cancer in Aotearoa New Zealand: The ACCORD study.
    STRATA Collaborative
    Colorectal Dis; 2024 Feb; 26(2):371-379. PubMed ID: 38124235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the watch-and-wait strategy suitable for every patient who has achieved a complete clinical response with neoadjuvant treatment in locally advanced rectum cancer?
    Akturk Esen S; Uncu D
    J Surg Oncol; 2024 Mar; 129(3):459-460. PubMed ID: 38031877
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-operative management in low-lying rectal cancers undergoing chemoradiation.
    Datta D; Engineer R; Saklani A; D'souza A; Baheti A; Kumar S; Krishnatry R; Ostwal V; Ramaswamy A; Patil P
    J Cancer Res Ther; 2024 Jan; 20(1):417-422. PubMed ID: 38554355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.